Financial Performance - The company's operating revenue for Q3 2021 was ¥925,552,781.77, representing a 35.70% increase compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2021 was ¥40,345,316.70, an increase of 8.61% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥41,878,391.43, showing a significant increase of 195.85% compared to the same period last year[5] - Total operating revenue for the first three quarters of 2021 reached ¥2,921,042,889.74, a significant increase of 77.2% compared to ¥1,649,072,407.48 in the same period of 2020[18] - Net profit for the third quarter of 2021 was ¥185,561,415.77, up 133.4% from ¥79,249,634.83 in the third quarter of 2020[20] - The total comprehensive income for the third quarter of 2021 was ¥185,423,614.24, compared to ¥79,301,380.20 in the same quarter of 2020, indicating strong performance[20] Assets and Liabilities - The total assets at the end of the reporting period reached ¥5,382,606,987.81, reflecting a 26.83% increase from the end of the previous year[6] - Total assets as of September 30, 2021, are RMB 5,382,606,987.81, up from RMB 4,244,064,045.60 at the end of 2020[16] - The total liabilities as of the end of the third quarter of 2021 amounted to ¥2,029,468,902.34, an increase from ¥1,800,816,698.93 at the end of the third quarter of 2020[19] - Total liabilities increased to RMB 1,916,806,207.84 from RMB 1,709,703,930.25 year-over-year[16] Equity and Shareholder Information - The company’s total equity attributable to shareholders increased by 37.24% to ¥3,352,987,402.47 compared to the previous year[6] - Total number of common shareholders at the end of the reporting period is 18,752[12] - The largest shareholder, Tianjin Bomaike Investment Holding Co., Ltd., holds 83,981,000 shares, accounting for 29.13% of total shares[12] Cash Flow - The company reported a net cash flow from operating activities of ¥28,559,080.12, which is a decrease of 94.49% compared to the previous period[6] - The net cash flow from operating activities for the first three quarters of 2021 was ¥28,559,080.12, a decrease from ¥518,204,041.86 in the same period of 2020[21] - The net cash flow from financing activities was $765,596,380.68, up from $233,976,922.87 year-over-year, reflecting improved financial health[22] - The company reported a net increase in cash and cash equivalents of $993,964,018.87, compared to $107,137,369.62 in the same period last year[22] - The ending balance of cash and cash equivalents was $1,619,468,548.86, significantly higher than the previous year's balance of $580,424,160.89[22] Research and Development - The company's research and development expenses increased by 124.55% year-on-year, indicating a strong focus on innovation[9] - Research and development expenses for the third quarter of 2021 were ¥145,632,044.22, significantly higher than ¥64,854,883.86 in the same quarter of 2020, indicating a focus on innovation[19] Other Financial Metrics - The basic earnings per share for Q3 2021 was ¥0.15, a decrease of 6.25% compared to the previous quarter[6] - Basic and diluted earnings per share for the third quarter of 2021 were both ¥0.77, compared to ¥0.35 in the same quarter of 2020, reflecting a 120% increase[21] - The company experienced a 413.15% increase in taxes payable, primarily due to an increase in taxable income[9] - The company completed a private placement, which significantly impacted its cash flow from financing activities, resulting in a 227.21% increase[9]
博迈科(603727) - 2021 Q3 - 季度财报